Precision BioSciences (DTIL) closed the last trading session at $9.71, gaining 1.7% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $39.61 indicates a 307.9% upside potential. The mean estimate comprises five short-term price targets with a standard deviation of $19.39. While the lowest estimate of $19 indicates a 95.7% increase from the current price level, the most optimistic ana ...